Nurse Practitioner, Family · Tifton, GA
NPI
1801301627
Since 2017
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1464 Carpenter Rd S
Tifton, GA, 31793
Phone (229) 353-2227
Groups this clinician bills Medicare through
Medicare paid, 2024
$29K
1,616 services
Medicare patients, 2024
164
Average age 70
Drug cost, 2024
$4.7M
4,151 prescriptions
Company payments, 2025
$3,551
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jessica A Boyd was code J1010 (injection, methylprednisolone acetate, 1 mg), 800 times for 16 patients. In total Jessica A Boyd billed 1,616 services in 24 codes, and Medicare paid $29K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-10-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 800 | 16 | $0.11 | $84.68 |
| 99214 Office E&M - Established | Office | 259 | 146 | $65.12 | $17K |
| 36415 Venipuncture Blood Collection | Office | 91 | 72 | $8.38 | $762 |
| 96372 Injection Administration | Office | 39 | 28 | $6.87 | $268 |
| 99215 Office E&M - Established | Office | 30 | 27 | $96.62 | $2,899 |
| 99213 Office E&M - Established | Office | 28 | 27 | $50.03 | $1,401 |
| 20611 Joint Injection | Office | 15 | 11 | $53.90 | $808 |
By year: 2023 $25K for 834 services; 2024 $29K for 1,616 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 91 | 72 | $8.38 | $762 |
Medicare prescription drug claims, 2024
In 2024, the drug Jessica A Boyd prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 486 prescriptions and refills. In total Jessica A Boyd wrote 4,151 Medicare prescriptions that cost $4.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 486 | 832 | 126 | $17K |
| Allopurinol Generic | 280 | 508 | 75 | $1,761 |
| Gabapentin Generic | 257 | 429 | 82 | $4,552 |
| Prednisone Generic | 204 | 260 | 60 | $954 |
| Methotrexate Methotrexate Sodium | 187 | 336 | 53 | $2,502 |
| Leflunomide Generic | 178 | 317 | 51 | $5,813 |
| Meloxicam Generic | 132 | 195 | 33 | $637 |
| Duloxetine Hcl Generic | 125 | 234 | 36 | $2,905 |
| Alendronate Sodium Generic | 116 | 189 | 30 | $593 |
| Baclofen Generic | 113 | 185 | 30 | $1,389 |
| Tizanidine Hcl Generic | 111 | 160 | 37 | $1,873 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 91 | 170 | 32 | $500 |
| Mycophenolate Mofetil Generic | 90 | 131 | 21 | $12K |
| Humira(Cf) Pen Adalimumab | 82 | 85 | 13 | $830K |
| Celecoxib Generic | 81 | 107 | 22 | $1,088 |
Brand drugs: 684 claims; generic drugs: 3,467 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jessica A Boyd $3,551 ($3,551 in general payments such as food, travel and fees) from 25 companies. The largest payer was Abbvie Inc. with $420.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 18 | $420 |
| Amgen Inc. AMGN | 23 | $407 |
| Mallinckrodt Hospital Products Inc. | 8 | $362 |
| Pfizer Inc. PFE | 17 | $339 |
| Janssen Biotech, Inc. JNJ | 5 | $308 |
| ANI Pharmaceuticals, Inc. ANIP | 10 | $250 |
| UCB, Inc. UCB.BR | 13 | $249 |
| GlaxoSmithKline, LLC. GSK | 8 | $184 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $137 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $127 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.